查詢結果分析
來源資料
相關文獻
- Defining VHL as a Prognostic Biomarker and Its Epigenetic Profiling for Breast Cancer
- Analysis of Spatial Transcriptomics of MARCH5 and Its Potential Role in Cell Proliferation in Breast Cancers
- γ-glutamylcyclotransferase as a Novel Clinicopathological Biomarker and Its Implication in Tumor Immune Microenvironment of Human Breast Cancer
- Mitochondrial Calcium Uniporter in Breast Cancer: The Clinical Prediction Value in Asians and the Involvement in the Shaping of Metastatic Niche
- Comprehensive Analysis of Circadian Genes in Diagnosis, Prognosis and Treatment Response in Breast Cancer
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Prenatal Diagnosis and Perinatal Outcome of Facial Clefts
- The Prognostic Significance of Pathologic Characteristics of Breast Cancer Patients in Taiwan
- 乳癌診斷施行準則
- 乳癌預後因子探討--論流式細胞分析儀在乳癌之應用
頁籤選單縮合
| 題 名 | Defining VHL as a Prognostic Biomarker and Its Epigenetic Profiling for Breast Cancer=將VHL定義為乳癌的預後生物標記及其表觀遺傳特徵分析 |
|---|---|
| 作 者 | 廖頌揚; 林宏昱; 朱旆億; | 書刊名 | 秀傳醫學雜誌 |
| 卷 期 | 24:2 2025.08[民114.08] |
| 頁 次 | 頁191-202 |
| 分類號 | 416.2352 |
| 關鍵詞 | 乳癌; 臨床病理學; 希佩爾-林道氏病腫瘤抑制因子; 診斷; 預後; 表觀遺傳譜; Breast cancer; Clinicopathology; Von Hippel-Lindau disease tumor suppressor; Diagnosis; Prognosis; Epigenetic profile; |
| 語 文 | 英文(English) |